Bastide Le Confort Médical SA — Cyborg Score 6/10

Solid
Medical Equipment Distribution & Home Care Services

Strategic Profile

The company benefits from demographic tailwinds driven by aging populations and healthcare demand. With 92.6% of revenue from France and a balanced revenue mix of 61% rental services and 39% equipment/consumables, Bastide operates a resilient recurring revenue model. The company has pursued strategic acquisitions including Oxigo to expand its service footprint and product capabilities.

Cyborg Score Rationale

Bastide operates in a defensive, growing market segment with recurring revenue streams and a stable customer base. However, the company shows modest profitability metrics (EPS of $0.08 on $534M revenue) and faces valuation headwinds with a $213M market cap. Limited geographic diversification (92.6% France-focused) presents concentration risk.

Top Insights

  • Revenue model is 61% recurring services (rental, installation, maintenance) providing cash flow stability
  • Heavy geographic concentration in France (92.6% of revenue) limits diversification and growth optionality
  • Operates three strategic business divisions: home care equipment, respiratory assistance, and perfusion/nutrition services
  • Recent leadership changes and M&A activity (Oxigo acquisition in 2023) suggest active management pursuing growth

Named Competitors

  • Medical Equipment Rental & Sales — Large diversified medical equipment manufacturers and distributors
  • Home Care Services — Fragmented regional competitors in home care and medical equipment rental

Recent Developments

  • (Jul 2023) Acquisition of Oxigo to expand service capabilities
  • (2025-2026) Leadership appointments including Deputy Chief Executive Officer for Operations and Development

Open the full interactive Bastide Le Confort Médical SA report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →